Moreover, a combination of three cancer stem cell markers - CD44, CD133 and SOX2 - was suggested to be a powerful and practicable prognosticator for patients with MEC of minor salivary glands [138]. The gene discussed is CD44; the disease is mucoepidermoid carcinoma.